The fundamental role and corollary effects of neuropeptides that govern cardio-respiratory control in the brainstem are poorly understood. One such regulatory peptide, catestatin (human chromogranin A 352-372 ), non-competitively inhibits nicotinic-cholinergic-stimulated catecholamine release. Previously, we demonstrated the presence of chromogranin A mRNA in brainstem neurons that are important for the maintenance of arterial pressure. In the current study, using immunofluorescence histochemistry, we show that catestatin-immunoreactivity is colocalized with tyrosine hydroxylase in C1 neurons of the rostral ventrolateral medulla (n=3). Furthermore, we investigated the effects of catestatin on resting blood pressure, splanchnic sympathetic nerve activity, phrenic nerve activity, heart rate, and adaptive reflexes. In urethane-anesthetized, vagotomized, ventilated, Sprague-Dawley rats (n=19), microinjections of catestatin (1mM, 50nl or 100µM, 50-100nl) were made into the rostral ventrolateral medulla. Cardiovascular responses to stimulation of carotid baroreceptors, peripheral chemoreceptors, and the sciatic nerve (somatosympathetic reflex) were analyzed.
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INTRODUCTION
In 1997, the catecholamine release-inhibitory cleavage product of Chromogranin A (CgA) was identified and named catestatin (Cts) (23). Cts inhibits acetylcholine and nicotineinduced catecholamine secretion in cell culture (21, 23), and studies in human suggest that it may play an important role in hypertension (38) .
Cts is unusual in its ability to function as an antagonist at neuronal nicotinic acetylcholine receptors (nAChR) and possibly other receptors, such as β-adrenoceptors and histamine H 1 receptors (8, 14, 25) , as opposed to directly activating specific 'Cts' receptors, as seen with other neurotransmitters and neuropeptides. Here we investigate the distribution of Cts in catecholamine-containing neurons of the brainstem and the physiological effects of Cts following microinjection into the rostral ventrolateral medulla (RVLM). The RVLM is comprised of a heterogeneous population of spinally projecting, barosensitive (presympathetic) neurons that are essential for tonic and reflex cardiovascular control (37) .
The activity of sympathetic preganglionic neurons (SPN) in the intermediolateral cell column is regulated by the presympathetic neurons projecting from the RVLM to the spinal cord (32) .
Neurons in the RVLM integrate information from diverse sources including baroreceptors, chemoreceptors, and somatosympathetic inputs (35) . Short-term control of RVLM neurons is largely regulated by glutamate and γ-aminobutyric acid (GABA). Presympathetic neurons also contain and release metabotropic neurotransmitters, including neuropeptides that exert long-term effects on cell function and which may affect adaptive reflexes (34) . The roles of neuropeptides in cardiovascular control remain to be fully elucidated.
Here we focus on the ability of Cts to influence cardio-respiratory function in the RVLM.
Recently, we reported that CgA mRNA-positive cells are co-localized with tyrosine hydroxylase (TH)-containing neurons in the rostral portion of the RVLM (8) . This region contains the densest population of sympathoexcitatory bulbospinal neurons projecting to SPN (30) .
Cts injected into the intrathecal (IT) space of the thoracic spinal cord does not affect resting mean arterial pressure (MAP), splanchnic sympathetic nerve activity (sSNA), or heart rate (HR) in urethane-anesthetized, vagotomized rats. However, IT Cts does significantly attenuate the cardiovascular effects of both nicotine and isoproterenol, suggesting it interacts with functional nAChRs and β-adrenoceptors in the spinal cord (8) . Here, we aimed to confirm that CgA is cleaved to produce Cts in the RVLM using fluorescence immunohistochemistry (IHC). Secondly, we aimed to determine if Cts affects basal blood pressure in the RVLM. Thirdly, we sought to explore a physiological role for Cts in cardiorespiratory control by microinjecting Cts into the RVLM and observing its effects on adaptive reflexes mediated by neurons in the RVLM.
METHODS

All procedures and protocols were approved by the Macquarie University Animal Ethics
Committee under the guidelines of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Experiments were conducted on adult male Sprague-Dawley rats (350-550g; Animal Resource Centre, WA) in accordance with these guidelines.
Brain tissue preparation. Rats (n=3) were anesthetized with pentobarbitone sodium (70mg/kg, i.p.). They were perfused transcardially with 400ml of 0.9% saline followed by fixation with 400ml of 4% paraformaldehyde in phosphate-buffer (0.1 M; pH 7.4). The brainstem was removed and fixed overnight in the same fixative at 4°C and coronally sectioned at 40μm using a vibrating microtome (Leica VT1000S, Wetzlar, Germany).
Fluorescence immunohistochemistry. IHC (n=3) was conducted as previously described (16) .
Primary antibodies: Rabbit anti-Cts (1:500, Phoenix Pharmaceuticals, H-053-29, prepared against this peptide RSMRLSFRARGYGFRDPGLQL, and has been shown to stain human adrenal medullary tissue) and mouse anti-TH (1:2000, Sigma-Aldrich, produced using rat TH). Mouse anti-TH was visualized by incubation overnight with a Cy3-conjugated donkey anti-mouse IgG secondary (1:500, Jackson, PA, USA). Rabbit anti-Cts was visualized by incubation overnight with a FITC-conjugated donkey anti-rabbit IgG secondary (1:500, Jackson, PA, USA). Further details can be found in the online supplement.
Surgical procedures. Rats (n=19) were initially anesthetized with a bolus injection of urethane (10%) diluted in saline (1.3-1.4g/kg i.p.; Sigma-Aldrich, St. Louis, MO) to provide a stable state of anesthesia. Depth of anesthesia was assessed by checking for the withdrawal reflex and arterial pressure changes (>10mmHg) in response to hind paw pinch. Intravenous doses of pentobarbital sodium (10mg in 20% solution) were delivered as required to suppress reflexes and maintain anesthesia. The left splanchnic and phrenic nerves were isolated and distal ends cut to enable recording of sSNA and phrenic nerve activity. The left sciatic nerve was isolated for stimulation. Nerve recordings and stimulations were made using bipolar platinum electrodes immersed in paraffin oil. Nerve activity was amplified, filtered (100-3000Hz), and sampled at 5000Hz using a Cambridge Electronic Design ADC system (model 1401; CED, Cambridge, UK) and Spike 2 analysis software (version 7.02). An occipital craniotomy was performed, exposing the dorsal medulla. Microinjections of glutamate (100mM, 50nl; Sigma-Aldrich), rat Cts (1mM, 50nl; Phoenix Pharmaceuticals), and vehicle (10mM phosphate-buffered saline [PBS] pH 7.4) were delivered bilaterally into the RVLM using single-barrel glass pipettes. The RVLM was located using microinjections of glutamate with a required MAP increase of >30mmHg when injected unilaterally, as described in previous studies (24) . The pipette was not removed from the electrode holder or exchanged during the course of the experiment. It was rinsed with PBS after glutamate was used to find the appropriate RVLM site. PBS control injections confirm that no glutamate remained in the pipette. Upon completion of the experiments, India ink was microinjected to mark the injection site and the brainstem was removed and fixed in 4% formaldehyde solution.
Histology was performed to confirm injection sites. Further details of experimental preparation can be found in the online supplement.
Experimental design. Cardiovascular reflexes were evoked as previously described (7, 33) .
Specific details can be found in the online supplement.
Data analysis. Data were analyzed as described previously (27, 29) . Nerve recordings were calibrated using a 50µV stimulus and integrated and smoothed for analysis (sSNA, time constant = 1 s; phrenic nerve activity, time constant = 50 ms). Baseline values were obtained by averaging 120 seconds of data 5 minutes pre-injection. Changes were expressed as a percentage of baseline activity. Amplitude of phrenic nerve discharge (PNA) and frequency of phrenic discharge (PNf; cycles/min) were used as a measure of inspiratory drive. Cardiorespiratory coupling was determined as previously described using cycle-triggered averages 
RESULTS
Cts is colocalized with tyrosine hydroxylase in RVLM neurons.
Cts-immunoreactivity (Cts-ir) was present in areas of the brainstem previously reported by others to contain CgA (41). Cts-ir was abundant in somata in the RVLM and was frequently present in TH-ir neurons ( Figure 1A -F). Cts-ir was found in 88.3 ± 1.5% of THimmunoreactive (TH-ir) neurons in the RVLM (average of 41 ± 6 cells out of 46 ± 7 cells across entire region counted; -11.6 to -12.6; n=3; Figure 1G ). Cts was frequently seen in neurons in the brainstem that were not TH-ir at sites previously shown to contain CgA (8, 41) .
Pilot studies (n=8) were carried out using 50 and 100nl bilateral microinjections of Cts (100μM, 1mM) into the RVLM. These pilot studies led to the finding that 50nl injections of Cts (1mM) were sufficient to elicit blood pressure responses exceeding 10mmHg.
RVLM microinjection of Cts increases MAP, sSNA, and PNA.
In six animals (resting levels: MAP 98 ± 4mmHg, sSNA 7.5 ± 0.9µV, PNA 11 ± 1µV, HR 458 ± 12bpm, PNf 40 ± 2 cycles/min), bilateral microinjections of Cts (1mM, 50nl) into the RVLM increased MAP, sSNA, and PNA (sample trace - Figure 2A ). RVLM injection sites were histologically confirmed ( Figure 2B ). Cts caused a short-lasting pressor response from baseline in MAP (28 ± 3mmHg; 2 min post-Cts; Figure 2C ), sSNA (15 ± 3%; 2 min post-Cts; Figure 2D ), and PNA (31 ± 4%; 10 min post-Cts; Figure 2E ). Cts did not significantly affect HR ( Figure 2F ) or PNf ( Figure 2G ). Peak effect on MAP and sSNA was observed 2-5 minutes after Cts microinjection, while maximal PNA effect was observed 10-12 minutes post-Cts. All parameters returned to pre-stimulus levels after 30-40 minutes elapsed. The degree to which MAP, sSNA, and PNA were increased by Cts was significantly greater than any effect seen due to bilateral microinjections of the vehicle (P<0.0001, Figure 2C -D;
P<0.05, Figure 2E ). Overall cardio-respiratory coupling was unaffected by Cts. Area under the curve for the inspiratory (I) and post-inspiratory (P-I) phases of sSNA did not significantly change between treatments (vehicle vs. Cts). However, the peak amplitude of sSNA was reduced by 40% compared with the response to PBS injection (P<0.03; graph not shown). The findings suggest a change in the appearance of the respiratory modulation of sympathetic nerve activity, but without any effect on neural minute ventilation.
Cts increases the slope of the sympathetic baroreflex.
In five animals, the sSNA response to PE was plotted against the MAP response to measure the effectiveness of the baroreflex. Cts increased sympathetic barosensitivity by 40% (slope = -0.05±0.01, R 2 = 0.96±0.01 after vehicle, compared with -0.07 ± 0.01, R 2 = 0.96±0.02 postCts, P= 0.003; Figure 3A -B).
Cts decreases sSNA response (somatosympathetic reflex) to sciatic nerve stimulation.
In five animals, sciatic nerve stimulation evoked a classic two-peak response in cylcle triggered averaged sSNA ( Figure 4A ), as seen in previous studies. (28) Figure 4B ).
Cts attenuates the peripheral chemoreflex.
In seven animals, anoxia (12s 100% Here, we used IHC to confirm that the CgA mRNA detected in the RVLM is processed into
CgA that reacts with an antibody raised against the Cts peptide sequence. The presence of Cts-ir in RVLM neurons suggests that Cts may act on presympathetic neurons and play an important role in cardio-respiratory regulation.
Cts increases mean arterial pressure and sympathetic nerve activity.
The idea that chemical coding in the brain controls cardio-respiratory function is supported by the differential effects observed when peptides and neurotransmitters are microinjected into brainstem nuclei. Neuropeptides tested using this approach in the RVLM include neuropeptide Y (NPY) (13, 26), orexin (19) , and galanin (2). In the current study, we demonstrate that microinjections of exogenous Cts into the RVLM evoke excitatory responses that result in increased sympathetic outflow and a subsequent increase in MAP.
Presumably this occurs through the activation of presympathetic neurons in the RVLM and subsequent activation of SPN that regulate the heart, blood vessels, and adrenal gland (37).
Interestingly, heart rate was not affected in these experiments, but this may be due to the fact that animals were vagotomised so that changes in heart rate would be small. In contrast, galanin and NPY both caused a decrease in MAP and HR, while sSNA was decreased by galanin and increased by NPY. These different effects support the idea that cardiovascular changes result from the summation of effects from a variety of neurotransmitters and peptides in the RVLM (18, 37 
Respiratory activity is increased by Cts.
Cts significantly increases PNA when microinjected into the RVLM. Anatomically, the RVLM is close to, and partly intermingled with, the Bötzinger complex (12, 36) . Therefore, the effects observed here on PNA are potentially due to direct spread of Cts to this region, or alternatively, activation of local interneurons that may in turn affect respiratory regulatory sites. It is extremely unlikely that spread to the preBötzinger region could occur as the rostral pole of this region is more than 500µm caudal to the injection sites and the diameter of our injections is no more than 350µm (17) .
Cts affects adaptive reflexes and contributes to the regulation of cardiovascular function.
Cholinergic inputs to the RVLM are thought to be responsible, to some degree, for sympathetic tone generation. Furthermore, in vitro studies suggest that sympathoexcitatory RVLM neurons have postsynaptic nAChRs and may be subject to an indirect cholinergic influence via interneurons (11) . Several studies show that Cts acts as an antagonist at nAChRs (8, 22, 23) . Tseng et al. reported that microinjection of nicotine into the RVLM caused an increase in MAP, HR, and renal SNA (44) . Hexamethonium (nAChR antagonist) inhibited this effect, establishing that the nicotine response was due to action at nAChRs (44) .
Interestingly, Cts, like nicotine, is excitatory in the RVLM, suggesting that here Cts acts through an alternate mechanism
In this study, we show that Cts potentiates the sensitivity of the sympathetic baroreflex in normotensive rats when injected into the RVLM. Previous studies demonstrate that CgA-null mice display a decreased baroreflex slope, which was restored by intravenous Cts (9). These observations suggest that Cts plays an important role in short-term blood pressure control.
Cts attenuates both peaks of the two-peak SSR response to sciatic nerve stimulation. The cardiovascular response to painful stimuli is largely coordinated in the RVLM (31) Cardiovascular responses to anoxia were used to quantify the peripheral chemoreflex. After
Cts, the pressor responses in MAP and sSNA to anoxia were reduced by half. This indicates that Cts plays a regulatory role in chemoreflex responses that maintain blood pressure and
sSNA.
Here we demonstrate that endogenous Cts is present in sympathoexcitatory neurons of the RVLM. Additionally, we found that when microinjected into the RVLM, Cts elevates MAP, sSNA, and PNA, increases barosensitivity, and attenuates the SSR and peripheral chemoreflex. Differential control of sympathetic outflow by specific populations of neurons has not been well established in the RVLM. However, this theory could explain why Cts caused an increase in MAP, but no change in HR. Microinjection of other substances, including peptides, also differentially affect adaptive reflexes (2, 13, 37). These neuropeptides, including Cts, alter the body's ability to respond to environmental stressors in dissimilar ways, suggesting that there may be populations of neurons in the RVLM that control different pathways of sympathetic outflow. The effects of Cts on adaptive reflexes observed here suggest a modulatory or smoothing action to decrease variability when blood pressure and sympathetic tone rise or fall.
At least three possibilities may account for the effects of Cts observed here. As previously mentioned, Cts interacts with multiple receptors; including the nicotinic acetylcholine and β-adrenergic receptors. Thus Cts may act through one or more classical receptors. A second view is that Cts acts through its own, as yet unidentified, receptor. Indeed, several 70-80 kDa membrane binding proteins have been reported for vasostatin I, suggesting that other CgA fragments have their own receptors (3 , 39) . Finally, we hypothesize that Cts has cell penetrating properties that allow it to cross the cell membrane and interact directly with intracellular signaling pathways.
PERSPECTIVES AND SIGNIFICANCE
The current hypothesis for the Cts mechanism of action is a negative feedback loop in which
Cts is co-released with catecholamines, and blocks further release by acting as a noncompetitive antagonist at nAChRs (20) . Studies in polymorphonuclear neutrophils (PMNs) demonstrate that Cts rapidly penetrates the cell membrane, much like cell penetrating peptides (CPP), to activate calcium-independent phospholipase A 2 (iPLA 2 ), leading to the production of lysophospholipids that induce the opening of store operated calcium channels (40, 46) . Calcium is a common second messenger involved in several signal transduction pathways controlling functions such as cell motility and secretion. CPPs are able to pass through the cell membrane because of specific domains in their structure that cause conformations and membrane surface orientations capable of inducing membrane curvature strain. Penetratin, derived from a Drosophila homeoprotein, and the HIV TAT peptide are the best documented CPPs (6) . These peptides are characterized as cationic, arginine and/or lysine rich, or amphipathic. The Cts amino acid sequence does not contain an extended hydrophobic region, amphipathic structure, or other specific indicator of its membrane interaction. However, Cts is cationic, its sequence aligns with the CPP penetratin ( ≥60% homology), and it induces calcium entry (42, 46) . Moreover, Cts lacks a tertiary structure in aqueous solutions, but forms α-helices in high concentrations of the zwitterionic detergent DPC (42) . The helical region of Cts contains arginine, which is common in CPPs; arginine is thought to form hydrogen bonds that aid CPPs in crossing the hydrophobic region of phospholipid bilayers (42) . While the possibility still remains that Cts acts through a surface receptor (e.g. nAchR, or its own receptor), these similarities suggest that Cts may translocate across cell membranes using a similar mechanism to penetratin, and is potentially a member of the CPP family (46) . If Cts is able to readily cross the cell membrane to increase calcium influx, and alter other intracellular pathways, this could be evidence of the neuroendocrine and immune systems working in concert and explain its apparently pleiotropic effects. Control Cts
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